ZeroHarm Sciences: Leading the Way in Plant-Based Nutraceuticals
Nano formulated plant based nutraceutical brand ZeroHarm Sciences has successfully secured Rs 65 crore ($7.15 million) in a Series A funding round. The investment saw Kotak Alternate Asset Managers Limited, via its Kotak Life Sciences Fund I, contributing Rs 40 crore, while Alkemi Growth Capital provided Rs 25 crore.
The funding will facilitate national brand development, facilitate international growth in regions such as the USA, the UK, and the Middle East, and enhance research and manufacturing capabilities, as reported in a press release from the company.
About ZeroHarm Sciences
Founded in 2020 by Sachin and Shweta Darbarwar, ZeroHarm Sciences is dedicated to creating health supplements derived from plant-based ingredients, utilising proprietary nano formulation technology. This innovative approach positions the company to establish India’s first Trust over Promise health platform, showcasing the effectiveness of supplements through quantifiable consumer health results.
Innovation in Nutraceuticals
The Hyderabad-based firm transforms plant-based nutrients into nano-sized particles, enhancing bioavailability and allowing for controlled release at reduced dosages. By merging ayurveda with cutting-edge technology, ZeroHarm offers preventive wellness solutions.
ZeroHarm manages the entire value chain, sourcing medicinal plants through a network of over 10,000 farmers located in Northeast India and the Himalayas. The company has successfully filed and received patents for its nano formulations, which include turmeric-based phytochemicals, iron folic acid combinations, carotenoid formulations for eye health, and synbiotic compositions for gut health.
Product Offerings
The company boasts over 60 SKUs across various categories including diabetes management, heart health, joint care, immunity, gut health, oncology support, women’s wellness, and performance nutrition. Products are available through its website as well as e-commerce platforms like Amazon, Flipkart, and quick commerce services, serving a customer base exceeding 300,000.
Market Potential
India’s nutraceutical market is anticipated to reach $18 billion by 2025, while the global market is projected to surpass $720 billion by 2027. ZeroHarm competes with notable brands such as Kapiva, Plix, HealthKart, and Wellbeing Nutrition.